Intended for in vitro diagnostic use, the Erythropoietin (EPO) ELISA kit is intended to aid in determining the cause of anemia and erythrocytosis (increase of red blood cell mass). EPO also is used to monitor AIDS patients undergoing AZT therapy and to monitor the drug Rx Epogen.
     Erythropoietin acts as the principal regulator in the production of red blood cells by controlling the number, the kinds, and the survival of the cells. Because of this ability, it is being investigated for use in cancer patients to prevent anemia, or to treat anemia that has been induced by chemotherapy and bone marrow transplantation.

Biomerica Inc
(949) 645-2111;